- +406.8% price growth over the last year
- +93.2% YTD performance
- Lower volatility than the market (beta 0.11)
On Monday, Immix Biopharma, Inc. stock price gained an impressive 5.11%
(Updated on Jun 29, 2026)
The Immix Biopharma, Inc. stock price gained 5.11% on the last trading day (Monday, 29th Jun 2026), rising from $9.98 to $10.49. During the last trading day the stock fluctuated 8.11% from a day low at $9.74 to a day high of $10.53. The price has risen in 8 of the last 10 days and is up by 24.14% over the past 2 weeks. Volume fell on the last day by -5 million shares and in total, 2 million shares were bought and sold for approximately $19.37 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $10.40, a level that may pose a second chance to hit a runner. According to fan-theory $13.05 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.
IMMX Signals & Forecast
Mostly positive signals in the chart today. The Immix Biopharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $9.75 and $9.09. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 33.29%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for Immix Biopharma, Inc. stock
Immix Biopharma, Inc. finds support from accumulated volume at $9.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.790 between high and low, or 8.11%. For the last week, the stock has had daily average volatility of 8.37%.
The Immix Biopharma, Inc. stock is extremely overbought on RSI14 (81). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.
Our recommended stop-loss: $10.19 (-2.88%) (This stock has high daily movements and this gives high risk. The RSI14 is 81 and this increases the risk substantially. There is a buy signal from a pivot bottom found 14 days ago.)
Trading Expectations (IMMX) For The Upcoming Trading Day Of Tuesday 30th
For the upcoming trading day on Tuesday, 30th we expect Immix Biopharma, Inc. to open at $10.25, and during the day (based on 14 day Average True Range), to move between $10.11 and $10.87, which gives a possible trading interval of +/-$0.766 (+/-7.58%) up or down from last closing price. If Immix Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 7.58% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $10.66 (1.62%) than the support at $9.98 (4.86%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Immix Biopharma, Inc. stock A Buy?
Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period.
Current score:
4.992
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 30, 2026 - $10.25 ( 2.26%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
IMMX Performance
Trading levels for IMMX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 11.04 | 5.27% |
| R2 | 10.74 | 2.40% |
| R1 | 10.56 | 0.621% |
| Price | 10.49 | |
| S1 | 9.95 | -5.13% |
| S2 | 9.77 | -6.91% |
| S3 | 9.46 | -9.79% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 10.66 | 1.62% |
| Price | 10.49 | |
| S1 | 9.98 | -4.86% |
| S2 | 8.72 | -16.87% |
| S3 | 8.67 | -17.35% |
FAQ
Click here for our free guide on how to buy Immix Biopharma, Inc. Stock.
Buy IMMX